Detection of del(16q) using the CBFB-MYH11 translocation dual fusion probe.

[1]  A. Bagg,et al.  Most Myeloid Neoplasms With Deletion of Chromosome 16q Are Distinct From Acute Myeloid Leukemia With Inv(16)(p13.1q22): A Bone Marrow Pathology Group Multicenter Study , 2017, American journal of clinical pathology.

[2]  E. Lippert,et al.  A novel cryptic insertion of CBFB into MYH11: importance of FISH probe design. , 2014, Cancer genetics.

[3]  F. Solé,et al.  Genetic diagnosis by comparative genomic hybridization in adult de novo acute myelocytic leukemia. , 2004, Cancer genetics and cytogenetics.

[4]  E. McGhee,et al.  Monosomy 16 as the sole abnormality in myeloid malignancies. , 2000, Cancer genetics and cytogenetics.

[5]  E. Estey,et al.  Cytogenetic and clinical correlates in AML patients with abnormalities of chromosome 16. , 1995, Leukemia.

[6]  M. Tomonaga,et al.  del(16)(q22) in a child with acute myeloid leukemia without bone marrow eosinophilia. , 1992, Cancer genetics and cytogenetics.

[7]  F. Behm,et al.  Prognostic importance of cytogenetic subgroups in de novo pediatric acute nonlymphocytic leukemia. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  K. Ohyashiki,et al.  Chromosome change at 16q22 in nonlymphocytic leukemia: clinical implication on leukemia patients with inv(16) versus del(16). , 1988, Leukemia.

[9]  C. Bloomfield,et al.  Partial deletion of the long arm of chromosome 16 and bone marrow eosinophilia in acute nonlymphocytic leukemia: a new association. , 1983, Blood.